Kalaris Therapeutics (KLRS) Stock Chart & Stock Price History $4.90 +0.01 (+0.20%) As of 10:08 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kalaris Therapeutics Stock Price Performance The Kalaris Therapeutics (KLRS) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 8.17%, reflecting recent market activity. As of the latest close, Kalaris Therapeutics traded at $4.89 with a market cap of $91.44 million and volume of 110,569 shares. Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+5.83%1 Month Performance+8.17%3 Month Performance+72.54% KLRS Stock Chart for Friday, October, 24, 2025 KLRS Chart by TradingView Kalaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/23/2025$4.38$4.89+11.64%$5.05$4.40110,569 shs$91.44 million10/22/2025$4.73$4.38-7.40%$4.70$4.2797,001 shs$88.46 million10/21/2025$4.90$4.73-3.47%$4.98$4.6468,285 shs$88.45 million10/20/2025$4.63$4.90+5.83%$5.07$4.52118,865 shs$91.63 million10/17/2025$4.79$4.63-3.34%$4.91$4.5080,005 shs$86.58 million10/16/2025$4.93$4.79-2.84%$5.00$4.7476,609 shs$89.58 million10/15/2025$5.10$4.93-3.33%$5.24$4.7387,118 shs$92.19 million10/14/2025$4.76$5.10+7.14%$5.24$4.64127,133 shs$95.37 million10/13/2025$4.45$4.76+6.97%$4.98$4.29283,792 shs$89.02 million10/10/2025$4.63$4.45-3.89%$4.90$4.35369,716 shs$83.22 million Get the Latest News and Ratings for KLRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/09/2025$6.59$4.63-29.74%$6.66$4.34591,680 shs$86.58 million10/08/2025$7.72$6.59-14.64%$8.21$6.50199,104 shs$123.23 million10/07/2025$8.03$7.72-3.86%$8.45$6.98329,336 shs$144.38 million10/06/2025$6.64$8.03+20.93%$8.81$6.64522,724 shs$150.16 million10/03/2025$7.09$6.64-6.35%$7.31$6.62111,743 shs$124.17 million10/02/2025$6.07$7.09+16.80%$7.62$6.08371,127 shs$132.58 million10/01/2025$5.78$6.07+5.02%$6.70$5.78130,091 shs$113.52 million09/30/2025$6.35$5.78-8.98%$6.79$5.75221,951 shs$108.09 million09/29/2025$5.61$6.35+13.19%$6.45$5.53219,392 shs$118.75 million09/26/2025$4.77$5.61+17.61%$5.80$4.75250,146 shs$104.91 million09/25/2025$4.53$4.77+5.30%$4.81$4.4180,754 shs$89.21 million09/24/2025$4.77$4.53-5.03%$4.93$4.45139,134 shs$84.71 million09/23/2025$4.40$4.77+8.41%$4.82$4.37142,820 shs$89.20 million Related Companies ANNX Stock Chart DMAC Stock Chart EDIT Stock Chart ALT Stock Chart CTNM Stock Chart DSGN Stock Chart MREO Stock Chart TECX Stock Chart GALT Stock Chart UPXI Stock Chart Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KLRS) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredTrump cannot stop this trainGallup reports that two-thirds of Americans now view socialism favorably — a shocking shift that one analyst s...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kalaris Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kalaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLRS Stock Alerts